IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Performance
Performance Report
Performance Report
Chandra Bhagat Pharma Ltd IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 10.20 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Beeline Capital Advisors is the merchant banker of Chandra Bhagat Pharma Ltd IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th December 2019.
Chandra Bhagat Pharma Ltd IPO posted revenues of ₹ 100.32 crores and PAT of ₹ 0.75 crores in FY20 on annualised basis.
Revenue:
₹ 100.05 Cr.
EBITDA Margin:
4.41
% 
Net Worth: ₹ 14.61 Cr.
Market Capitalisation:
₹ 38.48 Cr.
P/E:
51.00 times
P/BV: 1.55 times
EV/EBITDA: 14.66 times
Financial results of Chandra Bhagat Pharma Ltd IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Jul-19 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 85.94 | 82.86 | 58.06 | 55.90 | |
| Net Worth | 14.61 | 14.37 | 8.45 | 7.41 | |
| Total Debt | 26.83 | 27.82 | 21.75 | 20.50 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
33.35
100.05 |
106.28 | 97.06 | 89.79 | |
EBITDA
EBITDA on annualised basis |
1.47
4.41 |
4.67 | 4.75 | 4.39 | |
PAT
PAT on annualised basis |
0.25
0.75 |
0.63 | 1.03 | 0.66 | |
Chandra Bhagat Pharma Ltd IPO PAT Margin is 0.75 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Chandra Bhagat Pharma Ltd IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Jul-19 | FY19 | FY18 | FY17 |
|---|---|---|---|---|
| EBITDA Margin (%) | 4.41 | 4.39 | 4.89 | 4.89 |
| PAT Margin (%) | 0.75 | 0.59 | 1.06 | 0.74 |
| EPS (₹) | 0.46 | 1.17 | 3.09 | 1.97 |
| ROE (%) | 1.71 | 4.38 | 12.19 | 8.91 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 0.29 | 0.76 | 1.77 | 1.18 |
| Debt to Equity | 1.84 | 1.94 | 2.57 | 2.77 |
The market Capitalisation of Chandra Bhagat Pharma Ltd IPO is ₹ 38.48 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Chandra Bhagat Pharma Ltd IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Chandra Bhagat Pharma Ltd IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Chandra Bhagat Pharma Ltd IPO is ₹ 38.48 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Chandra Bhagat Pharma LtdIPO has a Price-to-Earnings (PE) ratio of 51.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Chandra Bhagat Pharma Ltd IPO reported revenue of ₹ 100.32 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Chandra Bhagat Pharma Ltd IPO provide insights into sales growth, market demand, and business scalability.
Chandra Bhagat Pharma Ltd recorded an EBITDA of ₹ 4.41 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Chandra Bhagat Pharma Ltd Profit After Tax (PAT) is ₹ 0.75 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 100.05 Cr.
EBITDA Margin:
4.41
%
Net Worth: ₹ 14.61 Cr.
Market Capitalisation:
₹ 38.48 Cr.
P/E:
51.00 times
P/BV: 1.55 times
EV/EBITDA: 14.66 times
Chandra Bhagat Pharma Ltd operates in Pharmaceutical and Marketing Pharmaceutical Critical Care & Health Care Products. The Issue is listed on BSE SME in Feb, 2020. Chandra Bhagat Pharma Ltd IPO size was 10.20 with Issue price of 51.00 .
Merchant Banker(s) of Chandra Bhagat Pharma Ltd IPO: Beeline Capital Advisors Private Limited
Chandra Bhagat Pharma Ltd IPO subscription was 1.65 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Chandra Bhagat Pharma Ltd IPO listed at a listing price of 51.76 against the offer price of 51.00.
The current market price of Chandra Bhagat Pharma Ltd is 56.00.
Why Us?
